Introduction
Osteoporosis currently afflicts over half of women and almost 30% of men aged over 60 years; this figure will grow as the population ages. Fractures-especially of the hip-result in considerable social and economic costs to the individual and to society, as well as leading to an appreciable mortality.
Bone mineral density measured with dual-energy x-ray absorptiometry is the 'gatekeeper' to osteoporosis treatments in New Zealand and the best way to estimate future fracture risk. Hence it is important to be familiar with some of the technical aspects of densitometry and its application in the community. Clarification of some of these areas may facilitate more effective utilisation.
What are the indications for bone mineral density (BMD) assessment?
The indications for BMD testing, as recommended on the Osteoporosis New Zealand website (http://www.bones.org.nz), are listed in Table 1 . As pointed out on the site, BMD should only be measured if it will impact management.
What is the accuracy?
The precision of DXA is approximately 1.0-1.5% for spine and total hip BMD. 1 DXA scanners have excellent long-term precision because their calibration is very stable and there are effective instrument quality control procedures (provided by the manufacturers) to detect any long-term drifts. The test-retest variation for spine and hip DXA is 2-3%, resulting in T-score accuracy errors of ± 0.5. 
What is the radiation dose?
The effective radiation dose is 1-10 µSv.
3 Context is provided in Table 2 .
Are spine or hip measurements better?
The best way of predicting fracture risk at any given site is to measure BMD at that site-for example, DXA of the proximal femur predicts femoral fracture better than measurements at other sites. 4 Similarly, for vertebral or wrist fractures.
The spine is the best site for follow-up measurements because treatment changes are usually the and 250 000 person-years of follow-up. 8 The Garvan Institute fracture risk calculator (http:// garvan.org.au/promotions/bone-fracture-risk/calculator) requires fewer data and emphasises past fractures and falls.
A recent study found that the Garvan Institute calculator overestimated hip fracture rates and FRAX (with BMD measurements) underestimated osteoporotic and hip fracture rates. 9 However, BMD should continue to be used to calculate fracture risk which informs treatment decisions.
How can BMD results be used to plan treatment?
BMD and/or fracture risk scores are used as the arbiters for osteoporosis treatment as treatment is considered cost-effective at certain thresholds of fracture risk. For example, Special Authority for Subsidy is granted under the Pharmac schedule 10 for alendronate according to the criteria in Table 4 . By comparison, the threshold for treatment is set at a hip fracture risk in the next 10 years of 4% in the United Kingdom and Sweden.
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Why are there discrepancies between hip and spine T-scores?
A number of factors can spuriously affect the T-(and Z-) score at the hip and spine, including 10 One significant osteoporotic fracture demonstrated radiologically and T-score ≤ -2.5 One significant osteoporotic fracture demonstrated radiologically, and either the patient is elderly, or densitometry scanning cannot be performed because of major logistical, technical or pathophysiological reasons Two significant osteoporotic fractures demonstrated radiologically T-score ≤ -3.0
Ten-year risk of hip fracture (according to FRAX or Garvan calculator) ≥ 3% Patient has had a Special Authority approval for zoledronic acid (underlying causeosteoporosis) or raloxifene
The patient is receiving systemic glucocorticosteriod therapy (≥ 5 mg per day prednisone equivalents) and has already received or is expected to receive therapy for at least three months; and • T-score ≤ -1.5; or • one significant osteoporotic fracture demonstrated radiologically; or • Special Authority approval for zoledronic acid (underlying causeglucocorticosteroid therapy) or raloxifene Normal BMD or 'mild osteopenia' (T-score not less than -1.5) 15 years 'Moderate osteopenia' (T-score between -1.5 and -2.0) 5 years 'Advanced osteopenia' (T-score between -2.0 and -2.5) 1 year largest at this site and the precision error is lower than at other sites.
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How do the fracture risk calculators compare?
The WHO Fracture Risk Assessment Tool (FRAX) algorithm (available at http://www.shef. ac.uk/frax) accounts for 14 risk factors (as listed in Table 3 ) in calculating 10-year probabilities of hip and major osteoporotic (humerus, forearm, hip or clinical vertebral) fractures. 7 It incorporates data from 12 independent fracture studies, over 60 000 men and women (from four continents)
SUMMARY
• DXA is a fast, reliable, low-radiation method for assessing BMD, which is the arbiter for osteoporosis treatment eligibility and the best determinant of future fracture risk.
• Web-based fracture risk calculators can utilise BMD data to provide further information for medical practitioners and patients.
• The interval for serial BMD assessment for detecting development of osteoporosis should be planned according to the previous DXA findings.
degenerative bone/joint disease and aortic calcification which leads to spuriously high BMD measurements. 12 However, some conditions do tend to preferentially affect BMD at the spine more than the hip (e.g. steroid use) or the hip over the spine (e.g. hyperparathyroidism).
How often should DXA be repeated?
The International Society of Clinical Densitometry (ISCD) currently recommends no more frequent than biennial re-testing, 13 formulated from the known precision of DXA equipment and that the normal rate of postmenopausal bone loss is 1-2% per year.
Prospective clinical study of postmenopausal women concluded that development of osteoporosis is adequately detected by DXA frequency stratified by previous DXA findings for that individual 14 (summarised in Table 5 ). In most instances, this is much less frequent than the minimum two-year interval recommended by ISCD. However, it is also suggested that patients with advanced osteopenia should have repeat testing in one year, which directly contradicts the ISCD's recommendation.
Are DXA results from different facilities interchangable?
No. Different facilities use different equipment made by different manufacturers which, in turn, utilise different reference databases. It is best, therefore, to use the same software for repeat scans wherever possible.
